HRP20040135A2 - Osteogenic growth oligopeptides as stimulants of hematoiesis - Google Patents

Osteogenic growth oligopeptides as stimulants of hematoiesis Download PDF

Info

Publication number
HRP20040135A2
HRP20040135A2 HR20040135A HRP20040135A HRP20040135A2 HR P20040135 A2 HRP20040135 A2 HR P20040135A2 HR 20040135 A HR20040135 A HR 20040135A HR P20040135 A HRP20040135 A HR P20040135A HR P20040135 A2 HRP20040135 A2 HR P20040135A2
Authority
HR
Croatia
Prior art keywords
gly
gli
tyr
cells
oligopeptide
Prior art date
Application number
HR20040135A
Other languages
English (en)
Croatian (hr)
Inventor
Bab Itai
Chorev Michael
Shteyer Arye
Muhlrad Andras
Mansur Nura
Gurevitch Olga
Greenberg Zvi
Rosini Sergio
Trasciatti Silvia
Perini Mario
Original Assignee
Yissum Research Development Company Of The Hebrew
University Of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Company Of The Hebrew, University Of Jerusalem filed Critical Yissum Research Development Company Of The Hebrew
Publication of HRP20040135A2 publication Critical patent/HRP20040135A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HR20040135A 2001-07-29 2001-07-29 Osteogenic growth oligopeptides as stimulants of hematoiesis HRP20040135A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2001/000700 WO2003011313A1 (en) 2001-07-29 2001-07-29 Osteogenic growth oligopeptides as stimulants of hematopoiesis

Publications (1)

Publication Number Publication Date
HRP20040135A2 true HRP20040135A2 (en) 2005-02-28

Family

ID=11043077

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040135A HRP20040135A2 (en) 2001-07-29 2001-07-29 Osteogenic growth oligopeptides as stimulants of hematoiesis

Country Status (19)

Country Link
US (1) US20050004037A1 (cs)
EP (1) EP1414480A1 (cs)
JP (1) JP2004536876A (cs)
KR (1) KR20040044436A (cs)
CN (1) CN1310672C (cs)
AU (1) AU2001282436B8 (cs)
BR (1) BR0117087A (cs)
CA (1) CA2456092A1 (cs)
CZ (1) CZ2004300A3 (cs)
EE (1) EE200400062A (cs)
HR (1) HRP20040135A2 (cs)
HU (1) HUP0400667A2 (cs)
IL (1) IL160016A0 (cs)
IS (1) IS7129A (cs)
MX (1) MXPA04000858A (cs)
NO (1) NO20040378L (cs)
NZ (1) NZ530904A (cs)
SK (1) SK912004A3 (cs)
WO (1) WO2003011313A1 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532261A (zh) * 2010-12-29 2012-07-04 中国医学科学院药物研究所 骨重建激活剂-酪脯肽及其药物组合物和用途
CN106726672A (zh) * 2016-12-29 2017-05-31 陕西慧康生物科技有限责任公司 一种化妆品组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5461034A (en) * 1989-02-23 1995-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth polypeptides identified from regenerating bone marrow
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5154921A (en) * 1990-07-13 1992-10-13 Dana-Farber Cancer Institute, Inc. Promotion of maturation of hematopoietic progenitor cells
DE4240635C2 (de) * 1992-12-03 1997-07-10 Lothar Prof Dr Kanz Vermehrung hämatopoetischer Vorläuferzellen ex vivo sowieZusammensetzungen hämatopoetischer Wachstumsfaktoren
IL104954A (en) * 1993-03-04 2006-08-01 Yissum Res Dev Co Use of osteogenic oligopeptides in the preparation of pharmaceutical compositions for the treatment of bone diseases and some such novel oligopeptides, pharmaceutical compositions containing them and their preparation
EP0721780A3 (en) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for promoting platelet and/or leukocyte production
CN1163262C (zh) * 1999-04-01 2004-08-25 上海益众生物技术有限公司 成骨生长肽药物组合物及制备方法和应用

Also Published As

Publication number Publication date
NZ530904A (en) 2005-09-30
EP1414480A1 (en) 2004-05-06
CZ2004300A3 (cs) 2005-03-16
IL160016A0 (en) 2004-06-20
AU2001282436B8 (en) 2008-05-01
CN1310672C (zh) 2007-04-18
HUP0400667A2 (hu) 2004-12-28
WO2003011313A8 (en) 2004-04-08
CA2456092A1 (en) 2003-02-13
AU2001282436B2 (en) 2008-03-06
WO2003011313A1 (en) 2003-02-13
EE200400062A (et) 2004-06-15
JP2004536876A (ja) 2004-12-09
KR20040044436A (ko) 2004-05-28
CN1551779A (zh) 2004-12-01
IS7129A (is) 2004-01-28
SK912004A3 (en) 2004-07-07
US20050004037A1 (en) 2005-01-06
BR0117087A (pt) 2004-08-03
MXPA04000858A (es) 2005-06-06
NO20040378L (no) 2004-03-26

Similar Documents

Publication Publication Date Title
Borge et al. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+ CD38− bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin
EP0812201B1 (en) In vitro amplification of stem cells
EP2094839B1 (en) Expansion of hematopoietic stem cells
US5426098A (en) Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
ES2321189T3 (es) Estimulacion de la hematopoyesis por medio de celulas inmunitarias activadas ex vivo.
CA2031233A1 (en) Megakaryocyte production
US20170252362A1 (en) Methods & compounds useful in hematopoietic stem cell medicine
WO2003038048A2 (en) Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
JP2002502617A (ja) 幹細胞および前駆細胞の増殖と分化を制御する方法
WO1998001151A1 (en) Novel use of mk family as hematopoietic factor
US5258367A (en) Uteroferrin and rose proteins for stimulating hematopoietic cells
Fazzi et al. Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice
ES2409128T3 (es) Procedimientos de mejora de anidamiento e injerto de células madre
AU2001282436B8 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
AU2001282436A1 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
Mahmud et al. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates
ZA200401552B (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis.
Kidd et al. In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice
Scott et al. Thrombopoietin signaling is required for in vivo expansion of IL-11–responsive hematopoietic progenitor cells in the steady state
McKenna et al. Biology of Flt3 ligand, a novel regulator of hematopoietic stem and progenitor cells
BG108586A (bg) Остеогенни растежни олигопептиди като стимуланти на хематопоезата
Rogers Tumor necrosis factor responsiveness of hematopoietic stem cells in mouse long-term bone marrow cultures
Su Ex vivo expansion of hematopoietic stem and progenitor cells from umbilical cord blood: Cytokine combinations, platelet-derived growth factor and stromal cell support
Deutsch et al. Post-irradiated canine serum (PICS-J) stimulates megakaryocyte (MK) progenitors and thrombopoiesis in-vitro
HK1164367A (en) Methods of improving stem cell homing and engraftment

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20070725

Year of fee payment: 7

OBST Application withdrawn